Additionally, the prognostic value of these autoantibodies was analyzed in a separate independent cohort of 354 patients with NSCLC.<h4>Results</h4>The expression levels of anti-DLAT and anti-LIAS autoantibodies were significantly elevated in NSCLC compared to those in BPN and NC. This evidence concerns the gene DLAT and non-small cell lung carcinoma.